GI & Endoscopy

Sam Moussa, MD, is a gastroenterologist at Tucson, Ariz.-based Adobe Gastroenterology.

SGS United Kingdom withdrew GI Dynamics' CE Mark for its EndoBarrier device.

After announcing positive results from its second phase III trial, Global Data Healthcare Analysts' Maria Sudul said Ardelyx's Tenapanor is in line to make a "successful market entry."

Lumendi completed the first-in-human trials of its DiLumen Endolumenal Interventional Platform technology, meeting the study's primary endpoint.

New York City-based South Brooklyn Endoscopy Center serves residents of the Brooklyn borough by performing 10,000 procedures annually.

Here are three practices and hospitals making headlines this past week.

The U.S. Patent and Trademarks Office granted Immuron a patent for its non-alcoholic steatohepatitis treatment.

Troy, Mich.-based Gastrointestinal Endoscopy Center is an AmSurg center providing patients with gastroenterology services.

Here are four updates on GI companies from the past week:

UC San Diego researchers discovered that a synthetic double-stranded RNA, plC, can boost anti-tumor innate immune functions in developing liver cancer.